1. "2016"
  2. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (93)
  2. Journal Article (66)
  3. Book Section (3)
Groups
  1. Bone Marrow Transplant (162)
  2. Center for Hematologic Malignancies (162)
  3. Department of Medicine (162)
  4. Hematologic Malignancies, Division of (152)
  5. Survivorship Research (76)
  6. Epidemiology and Biostatistics (52)

More Groups

People
  1. Sergio Giralt (73)
  2. Miguel-Angel Perales (69)
  3. Sean Devlin (45)
  4. Hugo Castro-Malaspina (31)
  5. Esperanza Papadopoulos (29)
  6. Ann Jakubowski (28)

More People

Years
  1. 2016 (162)
Publications
  1. Biology of Blood and Marrow Transplantation (49)
  2. Blood (48)
  3. Bone Marrow Transplantation (19)
  4. Journal of Clinical Oncology (5)
  5. British Journal of Haematology (3)
  6. Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation. 5th ed (3)

More Publications

Publishers
  1. Elsevier Inc. (52)
  2. American Society of Hematology (49)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (6)
  5. Wiley Blackwell (4)
  6. John Wiley & Sons (3)

More Publishers

Results (162)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction
    Meeting Abstract

    Merlini, G.; Liedtke, M.; Landau, H. J.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schonland, S.; Guthrie, S. D.; Walling, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Intestinal microbiota and relapse after hematopoietic-cell transplantation
    Meeting Abstract

    Peled, J.; Devlin, S.; Staffas, A.; Lumish, M.; Rodriguez, K. P.; Ahr, K.; Perales, M.; Giralt, S.; Taur, Y.; Pamer, E.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injuries
    Meeting Abstract

    Velardi, E.; Tsai, J. J. Y.; Argyropoulos, K. V.; Jae-Hung, S.; Lieberman, S.; Kreines, F.; Shono, Y.; Young, L.; Wertheimer, T.; Jenq, R. R.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Murine donor 1928z CAR T cells exert potent graft-versus-lymphoma activity without graft-versus-host-disease
    Meeting Abstract

    Smith, M.; Ghosh, A.; James, S.; Davila, M. L.; Velardi, E.; Argyropoulos, K. V.; Gunset, G.; Schietinger, A.; Sadelain, M. W.; van den Brink, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I trial of Janus kinase (JAK) inhibition with INCB039110 in acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Schroeder, M. A.; Khoury, H. J.; Jagasia, M.; Ali, H.; Schiller, G. J.; Arbushites, M.; Delaite, P.; Yan, Y.; Rhein, K.; Perales, M. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Patient-reported outcomes and patient-performed testing in measuring functional impairment after stem cell transplant in patients with multiple myeloma
    Meeting Abstract

    Shah, N.; Giralt, S. A.; Shi, Q.; Williams, L. A.; Bashir, Q.; Qazilbash, M.; Champlin, R. E.; Cleeland, C. S.; Wang, X. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Interim PET evaluation by Deauville criteria is an effective risk stratification tool in PTCL
    Meeting Abstract

    Mehta-Shah, N.; Ito, K.; Bantilan, K. S.; Moskowitz, A. J.; Sauter, C. S.; Horwitz, S. M.; Schoder, H.
    Blood (2016)

    Fulltext@MSK | Save